By Colin Kellaher
Innate Pharma has hired Jonathan Dickinson as the clinical-stage biotechnology company's next chief executive.
Innate said Dickinson, who most recently served as executive vice president and general manager for Europe at Incyte, joins the France-based company on Nov. 1 and will also serve as chairman of the executive board.
Herve Brailly, Innate's co-founder, has been serving as interim CEO and executive board chairman since the departure of Mondher Mahjoubi in January.
Innate said Brailly will remain for the next few months in an advisory role to assist with the transition, adding that it will propose that he join the board at the next opportunity.
Write to Colin Kellaher at colin.kellaher@wsj.com
(END) Dow Jones Newswires
October 14, 2024 07:40 ET (11:40 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。